日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer

DNA损伤反应特征与广泛期小细胞肺癌的一线化疗反应和肿瘤演变途径相关

Morris, Benjamin B; Heeke, Simon; Xi, Yuanxin; Diao, Lixia; Wang, Qi; Rocha, Pedro; Arriola, Edurne; Lee, Myung Chang; Tyson, Darren R; Concannon, Kyle; Ramkumar, Kavya; Stewart, C Allison; Cardnell, Robert J; Wang, Runsheng; Quaranta, Vito; Wang, Jing; Heymach, John V; Nabet, Barzin Y; Shames, David S; Gay, Carl M; Byers, Lauren A

Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations

非小细胞肺癌分子亚型及对免疫疗法联合治疗的敏感性

Lu, Tianshi; Hamidi, Habib; Socinski, Mark A; Reck, Martin; Cappuzzo, Federico; Barlesi, Fabrice; Jotte, Robert M; Müller, Sören; Qamra, Aditi; Amitai, Assaf; Guan, Xiangnan; Fuentes, Eloisa; Koeppen, Hartmut; Giltnane, Jennifer M; Shames, David S; Ballinger, Marcus; He, Meng Xiao; Wang, Yulei; Srivastava, Minu K; Nabet, Barzin Y

Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancer.

配体激活的 EGFR/MAPK 信号通路(而非 PI3K)是结直肠癌中 EGFR 疗法产生耐药性的关键机制

Qu Xueping, Hamidi Habib, Johnson Radia M, Sokol Ethan S, Lin Eva, Eng Cathy, Kim Tae Won, Bendell Johanna, Sivakumar Smruthy, Kaplan Benjamin, de Sousa E Melo Felipe, Mancini Andrew, Wongchenko Matthew, Shi Yi, Shames David, Yan Yibing, Ciardiello Fortunato, Bais Carlos

NOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STING

NOTCH1通过重新激活STING逆转小细胞肺癌中的免疫抑制。

Kim, Yoo Sun; Nabet, Barzin Y; Cortez, Briana N; Sun, Nai-Yun; Sebastian, Robin; Redon, Christophe E; Ray, Anagh; Liu, Liang; Ishola, Afeez A; Loew, Sarah; Dhall, Anjali; Sindiri, Sivasish; Gayevskiy, Velimir; Lee, Min-Jung; Rastogi, Shraddha; Sato, Nahoko; Kedei, Noemi; Andresson, Thorkell; Das, Sudipto; Kumar, Suresh; Bers, Alan E; Zhang, Hongliang; Chiappori, Alberto; Gopal, Priyanka; Abazeed, Mohamed E; Chen, Haobin; Aladjem, Mirit I; Pommier, Yves; Velez, Moises J; Shames, David S; Roper, Nitin

Development and validation of a serum proteomic test for predicting patient outcomes in advanced non-small cell lung cancer treated with atezolizumab or docetaxel

开发和验证一种血清蛋白质组学检测方法,用于预测接受阿特珠单抗或多西他赛治疗的晚期非小细胞肺癌患者的预后。

Srivastava, Minu K; Zou, Wei; McCleland, Mark; Roder, Joanna; Asmellash, Senait; Norman, Patrick; Net, Lelia; Maguire, Laura; Roder, Heinrich; Georgantas, Robert; Shames, David S

Real-World Validity of Tissue-Agnostic Circulating Tumor DNA Response Monitoring in Lung Cancers Treated With Chemotherapy, Immunotherapy, or Targeted Agents

组织非特异性循环肿瘤DNA反应监测在接受化疗、免疫疗法或靶向药物治疗的肺癌患者中的真实世界有效性

Chiang, Anne C; Madison, Russell W; Assaf, Zoe June; Fine, Alexander; Cao, Yi; Gjoerup, Ole; Huang, Yanmei; Jin, Dexter X; Hughes, Jason; Antic, Vladan; Young, Amanda; Fabrizio, David; Shames, David; Maund, Sophia; Exarchos, Alexia; Lakhanpal, Shailendra; Zuniga, Richard; Pasquina, Lincoln W; Schulze, Katja

Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

作者更正:新辅助阿特珠单抗治疗可切除非小细胞肺癌:一项开放标签、单臂 II 期试验

Chaft, Jamie E; Oezkan, Filiz; Kris, Mark G; Bunn, Paul A; Wistuba, Ignacio I; Kwiatkowski, David J; Owen, Dwight H; Tang, Yan; Johnson, Bruce E; Lee, Jay M; Lozanski, Gerard; Pietrzak, Maciej; Seweryn, Michal; Byun, Woo Yul; Schulze, Katja; Nicholas, Alan; Johnson, Ann; Grindheim, Jessica; Hilz, Stephanie; Shames, David S; Rivard, Chris; Toloza, Eric; Haura, Eric B; McNamee, Ciaran J; Patterson, G Alexander; Waqar, Saiama N; Rusch, Valerie W; Carbone, David P

Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T(reg) cells

出版商更正:抗TIGIT抗体通过髓系细胞和T(reg)细胞增强PD-L1阻断作用

Guan, Xiangnan; Hu, Ruozhen; Choi, Yoonha; Srivats, Shyam; Nabet, Barzin Y; Silva, John; McGinnis, Lisa; Hendricks, Robert; Nutsch, Katherine; Banta, Karl L; Duong, Ellen; Dunkle, Alexis; Chang, Patrick S; Han, Chia-Jung; Mittman, Stephanie; Molden, Nandini; Daggumati, Pallavi; Connolly, Wendy; Johnson, Melissa; Abreu, Delvys Rodriguez; Cho, Byoung Chul; Italiano, Antoine; Gil-Bazo, Ignacio; Felip, Enriqueta; Mellman, Ira; Mariathasan, Sanjeev; Shames, David S; Meng, Raymond; Chiang, Eugene Y; Johnston, Robert J; Patil, Namrata S

Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T(reg) cells

作者更正:抗TIGIT抗体通过髓系细胞和T(reg)细胞增强PD-L1阻断作用

Guan, Xiangnan; Hu, Ruozhen; Choi, Yoonha; Srivats, Shyam; Nabet, Barzin Y; Silva, John; McGinnis, Lisa; Hendricks, Robert; Nutsch, Katherine; Banta, Karl L; Duong, Ellen; Dunkle, Alexis; Chang, Patrick S; Han, Chia-Jung; Mittman, Stephanie; Molden, Nandini; Daggumati, Pallavi; Connolly, Wendy; Johnson, Melissa; Abreu, Delvys Rodriguez; Cho, Byoung Chul; Italiano, Antoine; Gil-Bazo, Ignacio; Felip, Enriqueta; Mellman, Ira; Mariathasan, Sanjeev; Shames, David S; Meng, Raymond; Chiang, Eugene Y; Johnston, Robert J; Patil, Namrata S

A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer

一种基于循环肿瘤DNA的纵向模型与转移性非小细胞肺癌的生存率相关

Assaf, Zoe June F; Zou, Wei; Fine, Alexander D; Socinski, Mark A; Young, Amanda; Lipson, Doron; Freidin, Jonathan F; Kennedy, Mark; Polisecki, Eliana; Nishio, Makoto; Fabrizio, David; Oxnard, Geoffrey R; Cummings, Craig; Rode, Anja; Reck, Martin; Patil, Namrata S; Lee, Mark; Shames, David S; Schulze, Katja